Skip to main content
Updating results

Pharmaceuticals Policy

  • Updated

A bill that would allow the state to cap the prices of certain high-cost prescription drugs stalled in a House committee Wednesday amid stiff opposition from the pharmaceutical and insurance industries.

WASHINGTON— Federal regulators are pressing the Supreme Court to stop big pharmaceutical corporations from paying ge-neric drug competitors to…

Get up-to-the-minute news sent straight to your device.


News Alerts

Breaking News